Operating Grant: TRANSCAN-3 (TRANSCAN-3 Joint Transnational Call for Proposals (JTC 2024) in Translational Research for New Combination Therapies Against Cancer)

The specific objective of this funding opportunity is:

• to improve the efficacy of personalized treatment of cancer patients through the development of new combinatorial treatment strategies, based on a better understanding of drug mechanistic functions and of their impact on the disease course.